pSG2.HIVconsv DNA vaccine(University of Oxford)

N/A

Report date: 2026/03/26 20:00:17

Base Information

Drug NamepSG2.HIVconsv DNA vaccine(University of Oxford)

Drug Alias NamepSG2.HIVconsv(University of Oxford)HIVconsv DNA vaccine(University of Oxford)

ClassificationVaccines > Development/production technology > Nucleic acid vaccine > DNA vaccineVaccines > Biological material > Viral vaccineVaccines > Application > Prophylactic vaccine

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsAcquired Immunodeficiency SyndromeHIV Infections

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited KingdomKenya

CombinationsNo

Global Highest StatusPending (Phase 2 Clinical)

Highest Status in ChinaN/A

Originator CompaniesUniversity Of Oxford

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesUniversity College London University Of Oxford

Active IndicationsN/A

Inactive IndicationsAcquired Immunodeficiency SyndromeHIV Infections

Other Information

ATC CodeN/A